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OBJECTIVE—Previous studies have found that high insulin
sensitivity predicts weight gain; this association has not been
conﬁrmed. Our aim was to systematically analyze metabolic
predictors of spontaneous weight changes.
RESEARCH DESIGN AND METHODS—In 561 women and
467 men from the Relationship Between Insulin Sensitivity and
Cardiovascular Disease (RISC) cohort (mean age 44 years, BMI
range 19–44 kg/m
2, 9% impaired glucose tolerance) followed up
for 3 years, we measured insulin sensitivity (by a euglycemic
clamp) and b-cell function (by modeling of the C-peptide re-
sponse to oral glucose and by acute insulin response to intrave-
nous glucose).
RESULTS—Insulin sensitivity was similar in weight gainers
(top 20% of the distribution of BMI changes), weight losers
(bottom 20%), and weight stable subjects across quartiles of
baseline BMI. By multiple logistic or linear regression analyses
controlling for center, age, sex, and baseline BMI, neither
insulin sensitivity nor any b-cell function parameter showed
an independent association with weight gain; this was true in
normal glucose tolerance, impaired glucose tolerance, and
whether subjects progressed to dysglycemia or not. Baseline
BMI was signiﬁcantly higher in gainers (26.1 6 4.1 kg/m
2)a n d
losers (26.6 6 3.7 kg/m
2) than in weight stable subjects (24.8 6
3.8 kg/m
2, P , 0.0001 for both gainers and losers). Baseline
waist circumference (or equivalently, BMI or weight) was a pos-
itive, independent predictor of both weight gain and weight loss
(odds ratio 1.48 [95% CI 1.12–1.97]) in men and (1.67 [1.28–2.12])
in women. In men only, better insulin sensitivity was an addi-
tional independent predictor of weight loss.
CONCLUSIONS—Neither insulin sensitivity nor insulin secre-
tion predicts spontaneous weight gain. Individuals who have
attained a higher weight are prone to either gaining or losing
weight regardless of their glucose tolerance. Diabetes 60:1938–
1945, 2011
T
he epidemic of obesity and the attendant in-
creased risk of diabetes and cardiovascular
disease pose a demand for devising and imple-
menting strategies to combat and/or prevent
obesity. Although much work has addressed the metabolic
consequences of weight gain, relatively few studies have
focused on the metabolic predictors of weight change.
Because insulin resistance is, like obesity, a major risk
factor for the development of diabetes, it is of special
interest to establish the relation of insulin resistance to
body weight changes. Several reports have examined the
relationship between insulin action and weight gain
(Table 1). An early investigation using the euglycemic
clamp technique in a small number of obese Pima Indians
(1) found that insulin sensitivity, not insulin resistance,
predicted spontaneous weight gain. Likewise, in a small
clinical study in women (5), clamp-based insulin sensitivity
predicted weight regain after initial weight loss. Other
studies using a variety of surrogate indices of insulin
sensitivity in larger groups of individuals, however, have
yielded mixed results, with roughly half of them reporting
an association between insulin sensitivity and weight gain
and the other half a relation of insulin resistance to sub-
sequent weight gain. With regard to insulin secretion,
again, the ﬁndings from studies using a host of proxies for
b-cell function have been inconclusive (Table 1).
In the present work, we examined the longitudinal data
of the Relationship Between Insulin Sensitivity and Car-
diovascular Disease (RISC) study, in which a large co-
hort of nondiabetic subjects underwent a standardized
euglycemic-hyperinsulinemic clamp to measure insulin
sensitivity and an oral glucose tolerance test (OGTT) and an
intravenous glucose tolerance test (IVGTT) to derive mea-
sures of b-cell function. Speciﬁcally, we asked the question
whether weight changes at follow-up, in either direction,
could be predicted by baseline insulin sensitivity and/or
b-cell function.
RESEARCH DESIGN AND METHODS
RISC is a prospective, observational, cohort study whose rationale and
methodology have been published previously (20). In brief, participants
were recruited from the local population at 19 centers in 13 countries in
Europe according to the following inclusion criteria: either sex, age 30–60
years (stratiﬁed by sex and by age according to 10-year age-groups), BMI
17–44 kg/m
2, and clinically healthy. Initial exclusion criteria were treatment
for obesity, hypertension, lipid disorders or diabetes, pregnancy, cardiovas-
cular or chronic lung disease, weight change of $5 kg in past month, cancer
(in past 5 years), and renal failure. Exclusion criteria after screening were
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E. REBELOS AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, JULY 2011 1939arterial blood pressure $140/90 mmHg, fasting plasma glucose $7.0 mmol/L,
2-h plasma glucose (on a standard 75-g OGTT performed in each subject)
$11.0 mmol/L or known diabetes, total serum cholesterol $7.8 mmol/L, serum
triglycerides $4.6 mmol/L, and electrocardiogram abnormalities. Baseline
examinations began in June 2002, were completed in July 2005, and included
1,538 subjects receiving an OGTT. Of these, 1,308 subjects also received a
euglycemic-hyperinsulinemic clamp; their baseline data have been published
(21).
All 1,308 subjects of the baseline cohort were recalled 3 years later and 1,048
(80%) participated in the follow-up evaluation. The baseline anthropometric
and metabolic characteristics of the 260 subjects who were lost to follow-
up were superimposable on those of the subjects who participated (data
not shown). The follow-up study included all the baseline measurements
(anthropometrics, routine blood chemistry, and OGTT) except for the glucose
clamp.
Local ethics committee approval was obtained by each recruiting center.
Participantsweregiven detailedwritten information onthestudy aswell asoral
explanation, and they all signed a consent form.
Lifestyle and medical history. Information was collected on personal and
family medical history of cardiovascular disease, stroke, hypertension, and
diabetes in ﬁrst-degree relatives, as well as information on smoking and alcohol
habits and physical activity.
Physical examination. Height was measured on a clinic stadiometer; body
weight and fat-free mass (FFM) were evaluated by the bioimpedance analysis
(Tanita International Division, U.K.), which has been shown to be highly
correlated with isotope-derived total body water (22). Waist, hip, and thigh
circumferences were measured by tape according to a standardized, written
protocol.
Physical activity. Of the 1,048 participants, 711 were ﬁtted with a CSA
Actigraph (MTI: Manufacturing Technology Inc., Fort Walton Beach, FL) at-
tached to a waist belt for 1 week. The Actigraph is a small (43 g), single-channel
recording accelerometer capable of continuous data collection for up to 22
days. Data are summed over 1-min periods and processed to evaluate energy
expenditure during the entire recording period as well as periods of moderate
and intense activity (23,24).
OGTT. Blood samples were taken before and at 30, 60, 90, and 120 min into the
OGTT. Blood samples were separated into plasma and serum, aliquotted, and
stored at 280°C for glucose, insulin, and C-peptide determination. Samples
were transported on dry ice at prearranged intervals to central laboratories.
Insulin clamp. On a separate day within 1 week of the OGTT, a euglycemic-
hyperinsulinemic clamp was performed in all subjects. Exogenous insulin was
infused at a rate of 240 pmol $ min
21 $ m
22 simultaneously with a variable 20%
dextrose infusion adjusted every 5–10 min to maintain plasma glucose level
within 0.8 mmol/L (615%) of the target glucose level (4.5–5.5 mmol/L).
IVGTT. In 761 of the 1,048 subjects with follow-up data, the acute insulin
response to intravenous glucose (AIR) was measured at the end of the clamp:
a glucose bolus (0.3 mg/kg body wt) was injected over 1 min; plasma glucose,
insulin, and C-peptide concentrations were measured at 2, 4, 6, and 8 min after
the bolus.
Analytical procedures. Plasma glucose was measured by the glucose oxidase
technique. Serum insulin was measured by a speciﬁc time-resolved immuno-
ﬂuorometric assay (AutoDELFIA, Insulin kit, Wallac Oy, Turku, Finland) with
the following assay characteristics: detection limit .3 pmol/L, intra- and
interassay variation 1.7 and 3.5%, respectively. The intra- and interassay co-
efﬁcient of variation was ,5a n d,10%, respectively.
Data analysis. Fat mass was obtained as the difference between body
weight and FFM. Glucose tolerance was categorized into normal glucose
tolerance (NGT; fasting plasma glucose ,6.11 mmol/L and 2-h plasma
glucose ,7.78 mmol/L), impaired glucose tolerance (IGT; fasting glucose
,7.00 mmol/L and 2-h glucose $7.78 and ,11.1 mmol/L), and impaired
fasting glycemia (IFG; fasting glucose $6.11 and ,7.00 mmol/L).
Insulin sensitivity wascalculatedastheMvalueduring theﬁnal40minofthe
2-h clamp (normalized to the FFM, mmol $ min
21 $ kgFFM
21) as well as the ratio
of the M value (21) to the mean plasma insulin concentration measured during
the same interval (M/I, in units of mmol $ min
21 $ kgFFM
21 $ nM
21). Area under
the time-concentration curve was calculated by the trapezium rule. Actigraph
readings were summarized as habitual activity (average number of counts per
day).
b-Cell function modeling. The model used to reconstruct insulin secretion
and its control by glucose has been previously described (25,26). In brief, it
consists of three blocks: 1) a model for ﬁtting the glucose concentration
proﬁle, the purpose of which is to smooth and interpolate plasma glucose
concentrations; 2) a model describing the dependence of insulin (or C-peptide)
secretion on glucose concentration; and 3) a model of C-peptide kinetics—the
two-exponential model proposed by Van Cauter et al. (27) to reconstruct in-
sulin secretion rate from C-peptide concentrations in which the model
parameters are individually adjusted to the subject’s anthropometric data.
Deconvolution of C-peptide concentrations yields fasting insulin secretion rate
and total insulin output (over the 2 h of the OGTT). The relationship between
insulin release and plasma glucose concentrations is then modeled as the sum
of two components. The ﬁrst component represents the dependence of insulin
secretion on absolute glucose concentration at any time point and is charac-
terized by a dose-response function relating the two variables. The charac-
teristic parameter of the dose response is its mean slope in the 5–7 mmol/L
glucose range, denoted here as b-cell glucose sensitivity. The dose response
is modulated by both glucose-mediated and non–glucose-mediated factors
(i.e., nonglucose substrates, gastrointestinal hormones, and neurotransmitters),
which are collectively modeled as a potentiation factor. The model parameters
are determined from the glucose and C-peptide data under a smoothness con-
straint on the potentiation factor.
An empirical index of b-cell function during the OGTT was calculated as the
insulinogenic index—the ratio of incremental insulin to incremental glucose
concentrations at 30 min into the OGTT (28). AIR was calculated as the mean
insulin increment between 2 and 8 min after glucose injection; this response
was also expressed as the mean C-peptide increment during the same time
interval (3).
Statistical analysis. Data are reported as mean 6 SD; variables with skewed
distribution are summarized as median and interquartile range and were log-
arithmically transformed for use in parametric statistical testing. Group values
were compared by the Mann-Whitney U test, the Kruskal-Wallis test for con-
tinuous variables, or the x
2 test for nominal variables; paired values were
compared by the Wilcoxon test. ANCOVA was used to adjust group compar-
isons for potential confounders (center, sex, age, and BMI). Simple associa-
tions were tested by Spearman r, and logistic regression was used to predict
outcome. Multiple regression analysis was carried out using a forward step-
wise model. A P value # 0.05 was considered statistically signiﬁcant.
RESULTS
The distribution of the BMI changes between baseline and
follow-up (Fig. 1) shows that in the whole cohort, both
men and women gained weight over 3 years (0.9 [4.6] and
0.9 [4.6] kg, respectively; P , 0.0001 vs. zero). On the basis
of attained changes of body weight at follow-up, subjects
were classiﬁed as weight gainers if the change in sex-
speciﬁc BMI was in the top quintile of the distribution of
BMI changes or as weight losers if the corresponding
change was in the bottom quintile of the distribution;
otherwise, subjects were considered to be weight stable.
The anthropometric and baseline metabolic variables for
these three groups are given in Table 2. In both gainers and
FIG. 1. Frequency distribution plot of BMI changes over 3 years of
follow-up in 577 women (top) and 471 men (bottom).
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stable subjects (Fig. 2). On the clamp, insulin sensitivity
was better in women than men across weight categories.
After controlling for sex only, insulin sensitivity was sig-
niﬁcantly lower in subjects whose weight changed in ei-
ther direction as compared with the weight stable group
when using the M value; this difference, however, was no
longer signiﬁcant when using the M/I value, that is, nor-
malizing the M value for the steady-state plasma insulin
concentration during the clamp (which did not differ across
weight change categories). Of the b-cell function parame-
ters, fasting insulin secretion and AIR were signiﬁcantly
different across groups (Table 2).
To further test whether insulin sensitivity was related to
weight change, we grouped subjects according to their
baseline insulin sensitivity (below or above the median)
and tested whether the corresponding weight changes,
used as a continuous variable, were different. As shown in
Fig. 3, insulin sensitivity was not signiﬁcantly associated
with weight change across quartiles of baseline BMI (when
using either the M value or the M/I index of insulin sensi-
tivity) or in those participants (n = 15) who had developed
type 2 diabetes at follow-up.
The gain in weight (or BMI or waist circumference) at
follow-up in gainers was larger than the corresponding
loss in the losers (Table 3). In a logistic regression model
adjusting for center and age, baseline waist circumference,
but not insulin sensitivity, was a signiﬁcant predictor of
a subject being a gainer (with the weight stable subjects as
the reference group). This result held true for men and
women (Fig. 4A) and was not altered when using quartiles
of baseline waist instead of the continuous variable or
when using baseline body weight, BMI, or the waist-to-hip
ratio instead of waist circumference as the predictor.
Moreover, the result was not affected by including any
other metabolic variable (physical activity, fasting insulin,
fasting insulin secretion, total insulin output, glucose sen-
sitivity, or AIR) in the model. Also, replacing M/I with M
(or quartiles thereof) did not change the outcome. In
a multiple regression model, the change in body weight (or
BMI) at follow-up, used as a continuous variable, was
signiﬁcantly dependent on baseline waist but not on in-
sulin sensitivity.
In these adjusted models, baseline glucose tolerance—
as category (i.e., IGT or NGT) or as mean glucose con-
centration during the OGTT—had no affect on subsequent
weight change.
When the same set of analyses (logistic and multiple
regression) were performed to compare weight losers with
weight stable subjects, we found that a higher waist cir-
cumference was a signiﬁcant independent predictor of
weight loss in both women and men. In the logistic model,
TABLE 2
Anthropometric and baseline metabolic characteristics by weight change at follow-up
Weight loser Weight stable Weight gainer
Men Women Men Women Men Women
n 96 117 281 349 95 110
Age (years)* 44 6 94 6 6 84 4 6 94 5 6 84 3 6 84 4 6 8
Weight (kg)*† 85 6 11 71 6 12 82 6 12 65 6 11 85 6 14 70 6 13
BMI (kg/m2)*† 26.8 6 3.1 26.3 6 4.3 25.7 6 3.2 24.1 6 3.9 26.7 6 3.8 25.5 6 4.3
Fat mass (%)*† 23 6 63 5 6 72 1 6 63 1 6 72 3 6 73 4 6 7
Waist (cm)*† 95 6 98 5 6 11 92 6 10 80 6 11 96 6 11 84 6 11
NGT/IFG/IGT (%) 8/0/0 9/0/2 24/1/1 29/0/3 8/0/0 9/0/1
Fasting glucose (mmol/L)* 5.23 6 0.53 4.93 6 0.6 5.21 6 0.49 4.98 6 0.51 5.12 6 0.48 4.94 6 0.70
2-h glucose (mmol/L)* 5.18 6 0.60 4.84 6 0.58 5.13 6 1.19 4.94 6 0.75 5.12 6 0.48 4.94 6 0.70
M( mmol $ kgFFM
21 $ min
21)*† 48 [23] 55 [29] 49 [24] 60 [25] 44 [23] 53 [20]
Steady-state plasma insulin (pmol/L) 407 [124] 397 [104] 397 [129] 393 [114] 409 [111] 390 [110]
M/I (mmol $ min
21 $ kgFFM
21 $ nM
21)* 110 [70] 137 [92] 116 [68] 154 [83] 103 [72] 138 [60]
Fasting insulin SR (pmol $ m
22 $ min
21)† 69 [33] 71 [38] 73 [41] 64 [34] 74 [44] 73 [36]
Total insulin output (nmol $ m
22) 38 [18] 41 [15] 39 [17] 39 [17] 39 [21] 40 [15]
Glucose sensitivity
(pmol $ m
22 $ min
21 $ mM
21)* 103 [68] 112 [100] 102 [68] 124 [92] 110 [64] 116 [87]
Rate sensitivity (nmol $ m
22 $ mM
21) 0.85 [1.1] 0.68 [1.08] 0.85 [1.2] 0.73 [1.31] 0.76 [1.29] 0.93 [1.2]
Potentiation ratio 1.59 [1.18] 1.71 [1.29] 1.75 [1.21] 1.76 [1.35] 1.72 [1.15] 1.46 [1.18]
AIR (pmol/L)*† 127 [192] 86 [165] 89 [208] 93 [157] 128 [169] 104 [155]
AIRCpep (pmol/L)* 791 [687] 696 [535] 743 [664] 609 [603] 838 [535] 677 [536]
Insulinogenic index (pmol/mmol) 75 [77] 78 [80] 73 [62] 74 [77] 75 [61] 80 [61]
Data are mean 6 SD and median [interquartile range] unless otherwise indicated. SR, secretion rate; AIRCpep, acute insulin response as the
C-peptide response. *Signiﬁcant for sex at P # 0.05 or less. †Signiﬁcant for weight category at P # 0.05 or less.
FIG. 2. BMI at baseline and follow-up in subjects in the top (gainers)
or bottom (losers) 20% of the distribution of BMI changes and in the
remainder of the population (stable). Plots are mean 6 SEM.
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of weight loss in men but not in women (Fig. 4B).
In a separate set of analyses, we sought to determine
whether insulin sensitivity or secretion was associated
with weight gain in those individuals whose glucose
tolerance deteriorated over the 3 years of follow-up. To
this end, we classiﬁed as progressors those individuals
(n = 128) who stepped up along the sequences NGT→IFG,
NGT→IGT, NGT→T2DM (type 2 diabetes), IFG→IGT,
IFG→T2DM, and IGT→T2DM between baseline and follow-
up. In comparison with subjects who were NGT both at
baseline and follow-up (n = 820), progressors had worse
insulin sensitivity (106 [79] vs. 137 [84] mmol $ kgFFM
21 $
min
21 $ nM
21; P , 0.0001) and b-cell glucose sensitivity
(95 [51] vs. 122 [81] pmol $ m
22 $ min
21 $ mM
21; P , 0.0001),
but without signiﬁcant differences between weight gainers
or losers and weight stable subjects. Insulin secretion,
basal and total, was higher in progressors than NGT stable
subjects, again, without signiﬁcant differences between
weight gainers or losers and weight stable individuals. Fi-
nally, by restricting the analysis to the progressors group,
there were no differences in insulin sensitivity, b-cell
glucose sensitivity, AIR, or insulin secretion (fasting and
total) between weight gainers or losers and weight stable
subjects.
DISCUSSION
The RISC cohort is composed of relatively young, essen-
tially healthy women and men of European descent. Dur-
ing 3 years of observation, the average weight of the
cohort increased spontaneously at a rate of 0.3 kg per year
(or 0.4% of initial body weight per year). Upon classifying
individuals into weight gainers or losers based on a purely
statistical criterion (the upper and lower sex-speciﬁc
quintile of the distribution of BMI changes), weight stable
subjects were the 281 men whose weight changed between
–2.9 and 5.4 kg and the 349 women whose weight changed
between –3.1 and 5.4 kg over 3 years. This is a rather lib-
eral deﬁnition of weight stability, which accounts not only
for body size (height and sex) but also for the upward
trending of weight gain of the entire cohort. More accu-
rately, per our deﬁnition, weight stable subjects were
those whose overall adiposity did not change much be-
yond the normal age-related trend.
The ﬁrst ﬁnding in this cohort is that baseline insulin
sensitivity, measured by the clamp technique, was not as-
sociated with subsequent weight gain or loss. This held
true also when comparing more insulin resistant with more
insulin sensitive subjects in different BMI strata, thereby
ruling out the possibility of missing an interaction between
baseline insulin sensitivity and adiposity on subsequent
weight changes. Furthermore, when accounting for po-
tential confounders—center, age, and baseline adiposity
(as indexed by waist girth, total body weight, or BMI)—in
a multivariate logistic model, the level of insulin sensitivity
was not a signiﬁcant predictor of weight gain in either men
or women (Fig. 4A).
The two previous studies that used the clamp to mea-
sure insulin sensitivity (1,5) arrived at the conclusion
that better insulin sensitivity predicts weight gain or con-
versely, that insulin resistance protects against weight gain
(1). The reasons for the discrepancy are multiple. The
study by Yost et al. (5) in 10 obese women actually found
an association between gain in insulin sensitivity in sub-
jects attaining a stable weight loss and amount of weight
regained 1.5 years later; thus, these results do not speak
for insulin sensitivity being a general predictor of weight
gain. The study by Swinburn et al. (1) was carried out in
192 young (age ;25 years), very obese (BMI = 35 kg/m
2)
FIG. 3. Weight change (mean 6 SEM) according to baseline insulin
sensitivity (as the median M value [top] or the M/I value [bottom])
across sex-speciﬁc quartiles of baseline BMI. Neither the insulin sen-
sitivity factor nor its interaction with BMI is statistically signiﬁcant
(P = 0.14 and P = 0.60, respectively, for M and M/I).
TABLE 3
Baseline clinical and metabolic phenotype according to subsequent changes in glucose tolerance
Weight loser Weight stable Weight gainer
Men Women Men Women Men Women
Body weight (kg)‡ 23.4 [3.0] 24.6 [3.5] 0.9 [2.4] 0.9 [2.8] 5.8 [3.1] 6.3 [3.3]
BMI (kg/m
2)‡ 21.1 [0.84] 21.65 [1.17] 0.29 [0.86] 0.35 [0.99] 1.86 [0.86] 2.32 [1.33]
Waist (cm)† 23 6 5 24 6 71 6 31 6 65 6 66 6 6
Data are median [interquartile range] and mean 6 SD. ‡Signiﬁcant for their interaction at P # 0.05. †Signiﬁcant for weight category at
P # 0.05.
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expanded group of adult Pima Indians reported that the
M value on the clamp was no longer a predictor of weight
gain when controlling for baseline body weight (17).
Also peculiar is the ﬁnding in this ethnic group that chil-
dren with fasting hyperinsulinemia—a proxy for insulin
resistance—have been reported to be at enhanced risk of
subsequent weight gain (8). On the other hand, although
no other study has used the gold standard method in
a large population sample, studies using surrogate indices
of insulin sensitivity (from fasting insulin to homeosta-
sis model assessment of insulin resistance [HOMA-IR] to
IVGTT-based indices) have yielded contradictory results
(Table 1). In some cases, the association between insulin
sensitivity and weight gain was not adjusted for con-
founders such as sex, age, or baseline weight. The current
study included a much larger cohort of men and women,
with BMIs ranging from lean to very obese, and our anal-
yses accounted for the main determinants of insulin
sensitivity, namely, sex, age, and BMI. In addition, we
used both categorical grouping (weight gainers or stable
weight) and the longitudinal changes in body weight as
a continuous variable, and we explored possible inter-
actions among potential predictors. It therefore seems
possible to conclude that in people of European ancestry,
insulin sensitivity per se has little bearing on future weight
changes.
We also systematically sought associations between
weight gain and b-cell function by calculating fasting in-
sulin secretion, insulinogenic index and total insulin out-
put, model-derived b-cell glucose sensitivity, and the AIR
load. Together, these parameters explore both the abso-
lute insulin secretory response and the sensitivity of the
secretory machinery to glucose stimulation. Some of these
parameters (e.g., fasting insulin secretion and AIR) were, if
anything, higher in gainers than stable weight subjects, as
expected from their higher baseline BMI. When accounting
for the latter (as well as insulin sensitivity), however, none
of the insulin secretion indices were found to be an in-
dependent predictor of weight gain.
It has been reported that insulin hyposecretion pre-
dicts and precedes weight gain in subjects at high risk for
diabetes, such as Pima Indians (3), and in whom the sub-
sequent hyperinsulinemia may be an adaptive response of
the central nervous system conferring resistance to further
weight gain. Although we did not reproduce this ﬁnding in
the whole cohort, we tested the hypothesis in the subgroup
of individuals whose glucose tolerance deteriorated at
follow-up (progressors). Baseline insulin sensitivity and
glucose sensitivity were impaired and absolute insulin se-
cretion was increased in these subjects as compared with
those who remained glucose tolerant over time. However,
there were no differences in any of the b-cell function
parameters between those who gained weight and those
who did not. Finally, neither insulin sensitivity nor insulin
secretion predicted weight changes in subjects with IGT at
baseline or among progressors.
The most consistent and powerful predictor of weight
gain was the initial body mass (whether indexed as weight,
BMI, or waist circumference), which resisted all statistical
adjustments in both the logistic and continuous analyses.
This ﬁnding has not emerged clearly even from large epi-
demiological studies and has not been emphasized (29–33).
Apparently unreported is the parallel result: that a higher
initial body weight also predicted spontaneous weight loss
and that again, neither insulin sensitivity nor insulin se-
cretion added to the prediction. Taken together, these
ﬁndings suggest that subjects who gain weight may derive
from the same pool of individuals in the general population
who strive to lose weight after weight gain. In other words,
FIG. 4. A: Multiple logistic regression for the odds of being a weight gainer according to baseline age, waist girth, and insulin sensitivity (as the
M/I). Odds ratios (ORs) and 95% CIs are calculated for 1 SD of the predictor variable. For each 10-cm increase in waist circumference, the OR is
1.48 (95% CI 1.12–1.97) in men and 1.67 (1.28–2.12) in women. When using M instead of M/I, the OR is 1.01 (0.76–1.36) for men and 0.89 (0.68–
1.17) for women. B: Multiple logistic regression for the odds of being a weight loser according to baseline age, waist girth, and insulin sensitivity
(as the M/I). ORs and 95% CIs are calculated for 1 SD of the predictor variable.
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are generally heavier than people with a healthy weight
control and may be captured in a phase of weight accre-
tion (weight gainers) or weight loss (weight losers) when
observed at some time point in follow-up (34,35). Serial
longitudinal observations may reveal, at least in some of
them, a pattern of alternate phases of weight gain and loss,
with an overall upward trajectory (36,37).
Of note is that in male, but not female, weight losers,
a better insulin sensitivity was also independently asso-
ciated with more weight loss at follow-up (Fig. 4B). Al-
though in the whole dataset insulin sensitivity showed
a modest, positive association (r =0 . 1 4 ,P , 0.0001) with
the level of physical activity (as assessed by the Acti-
graph), the ﬁnding in male weight losers could not be
explained by a higher level of physical activity (38).
Speciﬁc studies are needed to further explore the role of
insulin sensitivity in spontaneous, as opposed to diet-
induced (5), weight loss.
A limitation of the current study is the relatively short
follow-up. Nevertheless, our conclusions are likely to be
generalizable not only because of the sample size and
quality of the measurements but also because the starting
cohort was composed of relatively lean subjects at an
appropriate age to study factors related to weight gain.
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